Pharmacies and Drug Control
Pharmacies, pharmacists, and wholesale drug distributors face a complex web of state and federal licensing laws and regulations.
Our team’s deep understanding of the legal nuances can help you navigate commercial and federal healthcare program payor guidelines, laws and regulations pertaining to handling of controlled substances, and regulations for participation in the NPIA “own use” and 340B pricing programs.
We can help you understand the requirements and comply with the following:
- State board of pharmacy licensure and compliance
- DEA registration requirements
- DEA requirements for the purchase, sale, and custody of controlled substances
- Robinson-Patman Act anti-price discrimination parameters
- Nonprofit Institutions Act, or “own use” requirements
- 340B Drug Pricing Program participation and compliance
- Prescription Drug Marketing Act or PDMA requirements
Contact
View All ProfessionalsRelated
“Novo Nordisk’s uphill battle in the counterfeit weight loss craze”
Tom Moga was quoted in the Life Sciences Intellectual Property Review (LSIPR) article, "Novo…
Rx-tension: Temporary Rule Extends Telemedicine Flexibilities for Controlled Substance Prescribing
Providers now have until November 11, 2023, to continue prescribing controlled substances through…
180 Dykema Lawyers Listed in The Best Lawyers in America© 2023 and Best Lawyers “Ones to Watch”
Dykema, a leading national law firm, announced today that 180 of its attorneys, in multiple practice…